1 to 9 of 41 results

HIV market to grow 6% pa to 2013, but then slow due to generics


Sales of antiretroviral agents will drive substantial 6% annual growth in the HIV drug market through…

and Tenofovir Disoproxil FumarateAtriplaBristol-Myers SquibbEfavirenzEmtricitabineEmtrivaSustiva

Gilead files 2nd patent suit against Teva


Gilead Sciences has filed a law suit in the US District Court in New York against Teva Pharmaceuticals…

and Tenofovir Disoproxil FumarateAtriplaEfavirenzEmtricitabineEmtricitabine and Tenofovir Disoproxil FumaraEmtrivaGilead SciencesGiliad SciencesSustivaTenofovir Disoproxil FumarateTruvadaViread

Teva files ANDA on Gilead


US firm Gilead Sciences says it has received a Paragraph IV Certification notification advising that…

and Tenofovir Disoproxil FumarateAtriplaBristol-Myers SquibbEfavirenzEmtricitabineEmtrivaGilead SciencesGiliad SciencesSustivaTenofovir Disoproxil FumarateViread

1 to 9 of 41 results

Back to top